CLSPN expression based on
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Comparison | Statistical significance |
Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.31860000035711E-07 |
Normal-vs-Stage2 |
4.991700E-02 |
Normal-vs-Stage3 |
8.37890000000563E-05 |
Normal-vs-Stage4 |
3.275900E-02 |
Stage1-vs-Stage2 |
6.986000E-01 |
Stage1-vs-Stage3 |
1.294380E-02 |
Stage1-vs-Stage4 |
4.676000E-01 |
Stage2-vs-Stage3 |
1.116770E-01 |
Stage2-vs-Stage4 |
7.501000E-01 |
Stage3-vs-Stage4 |
2.988400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.93829413525282E-12 |
Normal-vs-AfricanAmerican |
1.365870E-04 |
Normal-vs-Asian |
1.988830E-01 |
Caucasian-vs-AfricanAmerican |
4.798000E-01 |
Caucasian-vs-Asian |
3.307600E-01 |
AfricanAmerican-vs-Asian |
4.668400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.02340366683984E-11 |
Normal-vs-Female |
2.89049999491198E-08 |
Male-vs-Female |
1.022850E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.642030E-04 |
Normal-vs-Extreme_Weight |
3.51619999999775E-05 |
Normal-vs-Obese |
1.76554999999912E-05 |
Normal-vs-Extreme_Obese |
4.070100E-02 |
Normal_Weight-vs-Extreme_Weight |
5.274000E-02 |
Normal_Weight-vs-Obese |
2.450400E-01 |
Normal_Weight-vs-Extreme_Obese |
1.619840E-02 |
Extreme_Weight-vs-Obese |
3.717500E-03 |
Extreme_Weight-vs-Extreme_Obese |
3.284000E-01 |
Obese-vs-Extreme_Obese |
1.137920E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.296800E-03 |
Normal-vs-Age(41-60Yrs) |
1.86960447123852E-11 |
Normal-vs-Age(61-80Yrs) |
1.55429999981749E-07 |
Normal-vs-Age(81-100Yrs) |
6.353900E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.873800E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.174200E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.233500E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.207600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.478400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.637200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
6.34740005001078E-09 |
Normal-VS-Type2 PRCC |
1.25449999999194E-06 |
Normal-VS-KIRP CIMP |
7.777500E-03 |
Normal-VS-Unclassified PRCC |
3.73350000000272E-05 |
Type1 PRCC-VS-Type2 PRCC |
2.291900E-02 |
Type1 PRCC-VS-KIRP CIMP |
1.817920E-02 |
Type1 PRCC-VS-Unclassified PRCC |
4.092500E-02 |
Type2 PRCC-VS-KIRP CIMP |
4.244100E-02 |
Type2 PRCC-VS-Unclassified PRCC |
7.576200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
3.700400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.371000E-04 |
Normal-vs-N1 |
1.840520E-04 |
Normal-vs-N2 |
2.153400E-01 |
N0-vs-N1 |
1.228150E-02 |
N0-vs-N2 |
4.018800E-01 |
N1-vs-N2 |
5.267400E-01 |
|
|